Choroidal metastasis
Cancer spread to the eye from elsewhere, most often breast or lung. It is the most common eye cancer in adults and may be the first sign.
What it is
Blood-borne spread of a cancer, usually breast in women or lung in men, to the richly perfused choroid; it is the most common intraocular malignancy in adults. Lesions are creamy-yellow, flat or dome-shaped, often multiple or bilateral, with much subretinal fluid.
Who gets it
Found in a sizeable minority of patients dying with widespread cancer. Breast and lung cancer cause most cases; in about a quarter of patients, often with lung cancer, the eye lesion appears before the primary is known.
Causes
- Breast carcinoma
- Lung carcinoma
- Less often kidney, gut, prostate, thyroid, skin melanoma or carcinoid tumours
Risk factors
- Known metastatic cancer, especially breast or lung
- Other blood-borne metastases (brain, bone, liver)
Pathophysiology
Tumour cells reach the choroid through the short posterior ciliary arteries, so most deposits lie at the posterior pole. They grow as flat infiltrates that leak fluid and lift the retina, rather than the mushroom shape of melanoma.
Symptoms and signs
- Blurred vision
- Flashes or floaters
- A shadow in the visual field
- Pain if the eye pressure rises or the lesion is large
- Sometimes none
Diagnosis
- Clinical
- Dilated fundus examination: creamy-yellow, ill-defined plaque or dome lesions, often with subretinal fluid and 'leopard spot' pigment clumping on the surface.
- Tests
- Systemic search for the primary and other metastases with oncology; biopsy of the eye lesion only when no other tissue is available.
- Imaging
- Ultrasound (moderate to high internal reflectivity, no mushroom shape), optical coherence tomography with a lumpy choroidal surface, fluorescein and indocyanine green angiography; staging CT or PET of the body and MRI of the brain.
Differential diagnosis
- Amelanotic choroidal melanoma
- Circumscribed choroidal haemangioma
- Choroidal osteoma
- Posterior scleritis
- Choroidal lymphoma
- Central serous chorioretinopathy
Yellow choroidal mass: metastasis or a look-alike?
| Lesion | Colour and shape | Number and eyes | Ultrasound | Key clue |
|---|---|---|---|---|
| Choroidal metastasis | Creamy-yellow plaque or low dome, lumpy surface on OCT | Often multiple or bilateral | Moderate to high internal reflectivity | Known or hidden cancer; fluid out of proportion to height |
| Amelanotic choroidal melanoma | Dome or mushroom shape with visible intrinsic vessels | Single, one eye | Low internal reflectivity (hollow) | No cancer history needed; slow growth |
| Circumscribed choroidal haemangioma | Orange-red dome near the disc or macula | Single, one eye | High internal reflectivity | Early bright filling and late washout on ICG angiography |
Goal of treatment
Preserve vision and comfort while the systemic cancer is treated.
Treatment
- Medical
- Systemic chemotherapy, hormonal, targeted or immunotherapy for the primary cancer often shrinks the eye lesions too.
- Procedure
- External beam radiotherapy, plaque brachytherapy or photodynamic therapy for lesions that threaten vision or do not respond.
- Follow-up
- Regular fundus review during cancer treatment; screen for brain metastases, which often coexist.
Complications
- Exudative retinal detachment
- Secondary glaucoma
- Loss of vision
- Painful blind eye
Common traps
- A choroidal mass without a cancer history cannot be a metastasis: in about a quarter of cases, often lung cancer, the eye lesion appears before the primary is known
- Uveal melanoma is the most common adult intraocular malignancy: metastasis is more common; melanoma is the most common primary intraocular malignancy
- Every choroidal metastasis needs local eye treatment: systemic therapy for the primary often shrinks the eye deposits, so local radiotherapy is kept for lesions that threaten vision or do not respond
- An eye biopsy is needed to confirm the diagnosis: the picture, imaging and tissue from an easier systemic site usually suffice; eye biopsy is kept for when no other tissue exists
- The workup ends once the eye is treated: brain metastases often coexist, so brain MRI and full staging belong to the assessment
Prognosis
Reflects widespread disease: survival is usually measured in months to a few years, depending on the primary tumour; local control in the eye is often good.
Test yourself
Think of the answer, then tap the question to see it.
A 55-year-old smoker with no known cancer has a creamy-yellow choroidal plaque with subretinal fluid. What is the next step?
A systemic search for a primary with oncology, starting with chest imaging because lung cancer often presents this way, plus brain MRI.
Why do choroidal metastases cluster at the posterior pole?
Tumour cells arrive through the short posterior ciliary arteries, which supply the posterior choroid.
Why does a mushroom shape argue against metastasis?
The mushroom forms when a melanoma breaks through Bruch membrane; metastases grow as flat infiltrates that leak rather than burst through.
A woman on systemic treatment for breast cancer has a small deposit away from the macula. Is eye radiotherapy needed?
Often not: systemic therapy frequently shrinks it. Monitor, and treat locally if it grows or threatens the fovea.
Connections
Educational information, not medical advice. For any symptom, see a health professional.
Sources: Choroidal Metastases (EyeWiki (American Academy of Ophthalmology), 2025); Ocular Melanoma (StatPearls Publishing (NCBI Bookshelf), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.

